Information

2013/07/01

Notice of Changing Representative

2013/06/28

Completion of F351 Ib clinical trials and receiving manufacture method patent approval for F351 in China.

2013/06/10

Notice of Payment for the 36th Round of Stock Options

2013/06/07

Receipt of Grant Notice and Record of Non-Operation Income at Shanghai Genomics Inc.

2013/06/04

Conclusion of the Contract for Acceptance of Investment from Third Party Into Beijing Continent

2013/05/30

CHI Bio-IT World Asia

2013/05/22

GNI Announces Third-Party Allotment and the Issuance of the 36th Round of Stock Options with Moving Strike

2013/05/21

8th International China Pharmaceutical R&D Summit

2013/05/15

Acceptance of Investment from Third Party Into Beijing Continent

2013/03/04

5th China & 3rd Asia Clinical Trials Outsourcing Congress